Phoenix Financial Ltd. - 14 Jul 2025 SCHEDULE 13G Report for Teva Pharmaceutical Industries Ltd Ordinary Shares, par value NIS 0.10 per share (TEVA)

Filing Manager
Phoenix Financial Ltd.
Reporting Manager
Phoenix Financial Ltd.
Security
Teva Pharmaceutical Industries Ltd Ordinary Shares, par value NIS 0.10 per share
Symbol
TEVA
Shares outstanding
1,147,663,152 shares
Disclosed Ownership
57,383,158 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
22 Jul 2025, 09:25:18 UTC
Date of event
14 Jul 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Phoenix Financial Ltd. disclosed 5% ownership in Teva Pharmaceutical Industries Ltd Ordinary Shares, par value NIS 0.10 per share (TEVA) on 14 Jul 2025."

Quick Takeaways

  • Phoenix Financial Ltd. filed SCHEDULE 13G for Teva Pharmaceutical Industries Ltd Ordinary Shares, par value NIS 0.10 per share (TEVA).
  • Disclosed ownership: 5%.
  • Date of event: 14 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 22 Jul 2025, 09:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Phoenix Financial Ltd. 5% 57,383,158 0 57,383,158 /s/ Eli Schwartz Vice President - Chief Financial

Sponsored